Judges Scientific plc (AIM:JDG)
4,595.00
+20.00 (0.44%)
Jul 28, 2026, 8:04 AM GMT
Judges Scientific Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Short-Term Investments | 19.4 | 19.6 | 13.7 | 20.8 | 18.41 |
Cash Growth | -1.02% | 43.07% | -34.13% | 12.99% | 18.58% |
Total Trade Receivables | 26.5 | 30.2 | 25.1 | 25.6 | 17.15 |
Inventory | 24.8 | 28.1 | 26.5 | 22.3 | 14.13 |
Total Current Assets | 70.7 | 77.9 | 65.3 | 68.7 | 49.69 |
Net Property, Plant & Equipment | 33.5 | 31.8 | 26.4 | 20.1 | 12.44 |
Other Intangible Assets | 26.6 | 36.7 | 35.6 | 44.4 | 5.06 |
Goodwill | 57.2 | 60.4 | 54.8 | 53.6 | 18.71 |
Other Long-Term Assets | 0.1 | - | 1.4 | 1.2 | 3.08 |
Total Assets | 188.1 | 206.8 | 183.5 | 188 | 88.98 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 24.5 | 29.9 | 24.6 | 25.9 | 19.37 |
Accrued Expenses | 2.4 | 0.9 | 2.5 | 2.2 | 1.73 |
Current Portion of Long-Term Debt | - | 1.7 | 6.2 | 6.2 | 4.66 |
Current Portion of Leases | 1.4 | 1.2 | 1.2 | 1 | 0.89 |
Other Current Liabilities | 1.3 | 1.5 | 0.5 | 36.5 | - |
Total Current Liabilities | 29.6 | 35.2 | 35 | 71.8 | 26.64 |
Long-Term Debt | 59.6 | 67.6 | 52.2 | 49.4 | 12.35 |
Long-Term Leases | 4.2 | 4.8 | 5.7 | 3.3 | 3.42 |
Other Long-Term Liabilities | 11 | 12 | 8 | 9 | 3.17 |
Total Long-Term Liabilities | 74.8 | 84.4 | 65.9 | 61.7 | 18.94 |
Total Liabilities | 104.4 | 119.6 | 100.9 | 133.5 | 45.58 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.3 | 0.3 | 0.3 | 0.3 | 0.32 |
Additional Paid-in Capital | 19.4 | 19.2 | 17.7 | 17.2 | 16.67 |
Accumulated Other Comprehensive Income | 26.5 | 26.5 | 26.9 | 4.1 | 2 |
Retained Earnings | 37.5 | 40.9 | 37.5 | 32.7 | 23.79 |
Total Common Shareholders' Equity | 83.7 | 86.9 | 82.4 | 54.3 | 42.78 |
Minority Interest | - | 0.3 | 0.2 | 0.2 | 0.62 |
Shareholders' Equity | 83.7 | 87.2 | 82.6 | 54.5 | 43.39 |
Total Liabilities & Equity | 188.1 | 206.8 | 183.5 | 188 | 88.98 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 65.2 | 75.3 | 65.3 | 59.9 | 21.32 |
Net Cash (Debt) | -45.8 | -55.7 | -51.6 | -39.1 | -2.91 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -6.78 | -8.26 | -7.79 | -6.08 | -0.45 |
Book Value | 83.7 | 86.9 | 82.4 | 54.3 | 42.78 |
Book Value Per Share | 12.39 | 12.88 | 12.45 | 8.45 | 6.69 |
Tangible Book Value | -0.1 | -10.2 | -8 | -43.7 | 19.01 |
Tangible Book Value Per Share | -0.01 | -1.51 | -1.21 | -6.80 | 2.97 |